Rebalix
Logo VanguardVanguard · sheet of 5 September 2026
ETF sheet · official issuer and register data

Vanguard FTSE Developed Europe UCITS ETF (EUR) Distributing

VEUR · IE00B945VV12 · EUR · domicile Ireland
Equity · EuropeSFDR art. 6 (inferred)
Index tracked: FTSE Developed Europe Index
TER
0.10%+ trans. 0.04%
Fund size
7.7 bn EUR
Tracking difference
+0.34%3-year avg
🇮🇹 tax rate
26.00%equity
Replication
Physical (sampled)
Income
Distributingquarterly
Launch 21 May 2013 · costs from the KID as of 2 Sept 2026 · 591 securities held · 11 venues (ESMA register)

The fund’s objective — in the issuer’s words

From the Key Information Document (KID) · 4 Aug 2026
The Fund employs a passive management – or indexing – investment approach, through physical acquisition of securities, and seeks to track the performance of the FTSE Developed Europe Index (the “Index”). The Index is comprised of large and mid-sized company stocks in developed markets in Europe. The Fund attempts to: 1. Track the performance of the Index by investing through physical acquisition in all constituent securities of the Index in the same proportion as the Index. Where not practicable to fully replicate, the Fund will use a sampling process.…

Performance since series start (in euro) — base 100

30 Jun 201331 Jul 2026 · dividends reinvested where declared by the issuer
2014201620182020202220242026327100327
High 327 (31 Jul 2026) · low 100 (30 Jun 2013) · last 327. Past performance is not indicative of future results.

Returns in euro

1 year+23.6%
3 years+50.5%
5 years+67.1%
10 years+160.4%
Since series start+227.0%

Risk · 1 / 3 / 5 years

Volatility (ann.)12.34%12.51%14.15%
Max drawdown−9.86%−16.76%−22.55%
Sharpe1.250.710.33
Sortino1.880.980.45
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · VEUR · IE00B945VV121
RebalixVEUR · IE00B945VV12 · sheet of 5 September 2026

Tracking difference — year by year

Fund minus index, complete calendar years · from issuer-declared series
YearFundIndexTD
2025+19.90%+19.54%+0.36%
2024+9.37%+9.07%+0.30%
2023+16.51%+16.16%+0.35%
2022−9.97%−10.25%+0.28%
2021+25.20%+24.86%+0.34%

Distributions · per share, in EUR

Frequency: quarterly · last 12 months: 1.2913 EUR (2.57% of NAV) · last ex-date 18 Jun 2026
YearPaymentsTotal (EUR)Dividend yield
202620.9629
202541.2786+3.26%
202441.1997+3.25%
202341.1061+3.38%
202241.0874+2.89%
Dividend yield: the year’s distributions over the share value (NAV) at the start of the year.

Holdings

Portfolio as declared by the issuer · 31 Jul 2026 · 591 securities · top-10 weight = 20.1%
Top holdingsWeight
ASML Holding NV4.3%
HSBC Holdings PLC2.4%
Roche Holding AG2.1%
Novartis AG2.0%
Nestle SA1.7%
Shell PLC1.7%
AstraZeneca PLC1.7%
Siemens AG1.6%
Banco Santander SA1.4%
Allianz SE1.3%
Countries (% of fund)
United Kingdom23.2%France14.7%Switzerland14.4%Germany13.3%Netherlands8.1%
Sectors (% of fund)
Financials25.9%Industrials18.5%Health Care12.7%Technology8.6%Consumer Staples7.7%

Listing venues

ESMA register (FIRDS) and official exchange lists
VEUR · Borsa Italiana (ETFplus), Euronext Amsterdam, Euronext Paris
· Börse Düsseldorf, Börse Frankfurt, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Tradegate Exchange
VGEU · Xetra (Deutsche Börse)
+ 16 unmapped venues (MTF, RFQ, professional)

Official documents

Clickable links in the PDF
KID · fund-docs.vanguard.com/ie00b945vv12_priipskid_en.pdf
Factsheet · fund-docs.vanguard.com/FTSE_Developed_Europe_UCITS_ETF_EUR_Distributin
Prospectus · fund-docs.vanguard.com/etf-prospectus-en.pdf
The live sheet, always up to date
rebalix.com/en/etf/IE00B945VV12
Series, distributions, holdings and documents refresh daily.
Sheet produced on 5 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV and total-return series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.

Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.

Rebalix · VEUR · IE00B945VV122